P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

BACKGROUND: We present a pre-specified interim analysis of an ongoing open-label, investigator-sponsored phase 1 trial (NCT02893137) testing safety/efficacy of a new rGBM treatment. The intervention combines personalized skull-remodeling (SR) surgery with TTFields and best-choice chemotherapy. SR-su...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Korshoej, A R, Lukacova, S, Sørensen, J H, Hansen, F L, Mikic, N, Thielscher, A, Cortnum, S O S, Guldberg, T L, Lassen-Ramshad, Y, Rahbek, C, Severinsen, K E, von Oettingen, G B
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144088/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.071
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
Načítá se...

Podobné jednotky